ArticleBlood cancer journal2025

Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia.

Calogero Vetro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.